Epidemiology of urinary bladder cancer: from tumor development to patient’s death
✍ Scribed by Cristiane Murta-Nascimento; Bernd J. Schmitz-Dräger; Maurice P. Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X. Real; Núria Malats
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 441 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To identify the location of one or more putative tumor suppressor genes that may be involved in urinary bladder cancer, we examined 82 such tumors for allelic losses at 19 microsatellite loci on 8p. Loss of heterozygosity was observed in 31 of the cases. Deletion mapping identified a commonly delete
High frequency loss of 3p21.3 region where RASSF1A located was demonstrated in several tumors. We aimed to investigate the methylation status of RASSF1A and the frequency of LOH in 3p21.3 region in bladder cancer. Three bladder cancer cell lines, 40 cases of bladder TCC and 14 cases of paired voided